Richardson, P. G., Xie, W., Jagannath, S., Jakubowiak, A., Lonial, S., Raje, N. S., . . . Anderson, K. C. (2014). A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma. American Society of Hematology.
Citação norma ChicagoRichardson, Paul G., et al. A Phase 2 Trial of Lenalidomide, Bortezomib, and Dexamethasone in Patients With Relapsed and Relapsed/refractory Myeloma. American Society of Hematology, 2014.
Citação norma MLARichardson, Paul G., et al. A Phase 2 Trial of Lenalidomide, Bortezomib, and Dexamethasone in Patients With Relapsed and Relapsed/refractory Myeloma. American Society of Hematology, 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.